Solid Tumor trials recruiting in New Jersey

All Solid Tumor trials nationally

Cities in New Jersey

Recruiting trials in New Jersey

• A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
  NCT06586957 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · New Jersey: Hackensack
• A Study of MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancer
  NCT05859074 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · New Jersey: Basking Ridge, Middletown, Montvale
• A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin), a Folate Receptor Alpha (FRα)-Targeting Antibody-drug Conjugate (ADC) in Participants With Selected Tumor Types
  NCT04300556 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · New Jersey: Camden
• A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors
  NCT07094204 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · New Jersey: Hackensack
• DESCANSO, a Mental Health Intervention for Depression, Insomnia, and Fatigue Symptoms in Latino People With Cancer
  NCT07225088 · Phase: Not applicable (e.g. observational or device study) · Ages: 21 Years to 100 Years · Sex: All (male and female) · New Jersey: Basking Ridge, Middletown, Montvale
• Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion
  NCT05245500 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · New Jersey: New Brunswick
• RAPA-201 Therapy of Solid Tumors
  NCT05144698 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · New Jersey: Hackensack
• Study of Induction PD-1 Blockade in Subjects With Locally Advanced Mismatch Repair Deficient Solid Tumors
  NCT04165772 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · New Jersey: Basking Ridge, Middletown, Montvale
• Study of TJ033721 (Givastomig) in Subjects With Advanced or Metastatic Solid Tumors
  NCT04900818 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · New Jersey: New Brunswick
• Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
  NCT05176483 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · New Jersey: East Brunswick, Hackensack